(3β,20β)-3-acetoxy-11-oxoolean-12-en-29-oic acid

Uses at industrial sites

Uses at industrial sites

Registration/ Notification status for the use:

use registered according to REACH Article 10; total tonnage manufactured/imported <10tonnes/year per registrant

Use name:

Use as intermediate for trasformation in farma product

Regulatory status:

other: as intermediate for pharma product

Reference

Name:

3β,20β)-3-acetoxy-11-oxoolean-12-en-29-oic acid

Type of composition:

boundary composition of the substance

State / form:

solid: bulk

Reference substance:

3β,20β)-3-acetoxy-11-oxoolean-12-en-29-oic acid

Contributing activity / technique for the environment

Name of activity / technique:

trasformation

Environmental release category (ERC):

ERC6a: Use of intermediate

Contributing activity / technique for workers

Name of activity / technique:

intermediate for trasformation in pharma product

Process category (PROC):

PROC 2: Chemical production or refinery in closed continuous process with occasional controlled exposure or processes with equivalent containment conditions

PROC 3: Manufacture or formulation in the chemical industry in closed batch processes with occasional controlled exposure or processes with equivalent containment conditions

PROC 4: Chemical production where opportunity for exposure arises

PROC 5: Mixing or blending in batch processes

PROC 8b: Transfer of substance or mixture (charging and discharging) at dedicated facilities

PROC 9: Transfer of substance or mixture into small containers (dedicated filling line, including weighing)

Product category used:

PC 29: Pharmaceuticals

Sector of end use:

SU 8: Manufacture of bulk, large scale chemicals (including petroleum products)

Substance supplied to that use in form of:

as such

Subsequent service life relevant for this use:

no